435 results on '"Kelman, Jeffrey A."'
Search Results
2. Assessment of potential adverse events following the 2022–2023 seasonal influenza vaccines among U.S. adults aged 65 years and older
3. Incidence rates of thrombosis with thrombocytopenia syndrome (TTS) among adults in United States commercial and Medicare claims databases, 2017–2020
4. Risk of Severe COVID-19 in Prevalent Users of Alpha-1 Adrenergic Receptor Antagonists: A National Case-Control Study of Medicare Beneficiaries
5. Disparities in erythropoiesis-stimulating agent use after changes in medicare reimbursement and implementation of a risk evaluation and mitigation strategy
6. Evaluation of potential adverse events following COVID-19 mRNA vaccination among adults aged 65 years and older: Two self-controlled studies in the U.S.
7. Uptake and Competition Among Biosimilar Biological Products in the US Medicare Fee-for-Service Population
8. Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing COVID-19- Related Thromboembolic Events Among Medicare Enrollees Aged [greater than or equal to] 65 Years and Those with End Stage Renal Disease--United States, September 2022-March 2023
9. Risk of Covid-19-Related Hospitalization and More Severe Outcomes in Medicare Beneficiaries Treated with Renin-Angiotensin-Aldosterone System Inhibitors for Hypertension
10. Stroke Risk After COVID-19 Bivalent Vaccination Among US Older Adults
11. Risk of Adverse Events Following Monovalent Third or Booster Dose of COVID-19 mRNA Vaccination in U.S. Adults Ages 18 Years and Older
12. Uptake and Usage Patterns of Biosimilar Infliximab in the Medicare Population
13. Dispensing pharmacy chains and direct anticoagulants: Potential associations with patient outcomes
14. Severe Hypocalcemia With Denosumab Among Older Female Dialysis-Dependent Patients
15. Biosimilar Uptake in Medicare Advantage vs Traditional Medicare
16. Observations from the emergency management of dialysis patients evacuated from the US Virgin Islands to Puerto Rico following hurricane Irma
17. Comparative Stroke, Bleeding, and Mortality Risks in Older Medicare Patients Treated with Oral Anticoagulants for Nonvalvular Atrial Fibrillation
18. Patterns of seasonal influenza activity in U.S. core-based statistical areas, described using prescriptions of oseltamivir in Medicare claims data
19. Sepsis Among Medicare Beneficiaries: 4. Precoronavirus Disease 2019 Update January 2012–February 2020
20. Second cancers in adults with acute promyelocytic leukemia treated with or without arsenic trioxide: a SEER-medicare analysis
21. Real-world Effectiveness of mRNA COVID-19 Vaccines Among US Nursing Home Residents Aged ≥65 Years in the Pre-Delta and High Delta Periods.
22. Comparing the Centers for Medicare and Medicaid Services (CMS) enrollment data death dates to the National Death Index (NDI).
23. Using machine learning to improve anaphylaxis case identification in medical claims data
24. Assessment of Potential Adverse Events Following the 2022–2023 Seasonal Influenza Vaccines Among U.S. Adults Aged 65 Years and Older
25. Statin Use and Risks of Influenza-Related Outcomes Among Older Adults Receiving Standard-Dose or High-Dose Influenza Vaccines Through Medicare During 2010–2015
26. Beneficiary characteristics and vaccinations in the end-stage renal disease Medicare beneficiary population, an analysis of claims data 2006–2015
27. Pneumococcal Vaccination Among Medicare Beneficiaries Occurring After the Advisory Committee on Immunization Practices Recommendation for Routine Use Of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults Aged ≥65 Years
28. Effectiveness and Duration of Protection Provided by the Live-attenuated Herpes Zoster Vaccine in the Medicare Population Ages 65 Years and Older
29. Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries in Preventing Postinfluenza Deaths During 2012–2013 and 2013–2014
30. Near real-time surveillance for Guillain-Barré syndrome after influenza vaccination among the Medicare population, 2010/11 to 2013/14
31. Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing COVID-19-Related Thromboembolic Events Among Medicare Enrollees Aged ≥65 Years and Those with End Stage Renal Disease -- United States, September 2022-March 2023.
32. Sepsis Among Medicare Beneficiaries: 2. The Trajectories of Sepsis, 2012–2018*
33. Sepsis Among Medicare Beneficiaries: 1. The Burdens of Sepsis, 2012–2018*
34. Sepsis Among Medicare Beneficiaries: 3. The Methods, Models, and Forecasts of Sepsis, 2012–2018*
35. Characterization of Long COVID among U.S. Medicare Beneficiaries using Claims Data
36. Immune globulin usage trends in commercially insured and Medicare populations, 2009–2019
37. Evaluation of Potential Adverse Events Following COVID-19 mRNA Vaccination Among Adults Aged 65 Years and Older: A Self-Controlled Study in the U.S
38. Surveillance of COVID-19 vaccine safety among elderly persons aged 65 years and older
39. Early Dialysis and Adverse Outcomes After Hurricane Sandy
40. Comparative Effectiveness of Cardiac Resynchronization Therapy Defibrillators Versus Standard Implantable Defibrillators in Medicare Patients
41. Dialysis Care and Death Following Hurricane Sandy
42. Disparities in erythropoiesis-stimulating agent use after changes in medicare reimbursement and implementation of a risk evaluation and mitigation strategy
43. Mortality Among Parkinson’s Disease Patients Treated With Pimavanserin or Atypical Antipsychotics: An Observational Study in Medicare Beneficiaries
44. Pediatric Use of Antipsychotic Medications Before and After Medicaid Peer Review Implementation
45. Antihypertensive drug associated angioedema: effect modification by race/ethnicity
46. Background Rates of Adverse Events of Special Interest for COVID-19 Vaccine Safety Monitoring in the United States, 2019–2020
47. Trends in Influenza and Pneumococcal Vaccination Among US Nursing Home Residents, 2006-2014
48. Seasonal influenza vaccination is associated with reduced risk of death among Medicare beneficiaries☆
49. Risk of Guillain-Barré Syndrome Following Recombinant Zoster Vaccine in Medicare Beneficiaries
50. Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.